Evaluation of the immune response to a 2-dose measles vaccination schedule administered at 6 and 9 months of age to HIV-infected and HIV-uninfected children in Malawi

Clicks: 317
ID: 115255
2008
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
An early, 2-dose MV schedule was immunogenic, but a higher proportion of HIV-infected children remained susceptible to measles, compared with HIV-uninfected children (whether HIV exposed or HIV unexposed).
Reference Key
rf2008theevaluation Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Helfand RF;Witte D;Fowlkes A;Garcia P;Yang C;Fudzulani R;Walls L;Bae S;Strebel P;Broadhead R;Bellini WJ;Cutts F;;
Journal The Journal of infectious diseases
Year 2008
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18828743
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't female male Infant Randomized Controlled Trial Antibodies Measles Vaccine / administration & dosage* viral / blood hiv-1 / immunology hiv infections / immunology* measles vaccine / immunology* measles virus / immunology* kaplan-meier estimate measles / prevention & control* vaccination* malawi felicity cutts pmid:18828743 doi:10.1086/592756 rita f helfand desiree witte demography immunocompromised host / immunology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.